The innovative drug concept continues to strengthen, Hotgen rises over 15%, reaching a historic high

The innovative drug concept has repeatedly strengthened, with Hotgen rising over 15%, continuing to set new historical highs. Previously, Saili Medical had four consecutive trading limits, Zhongyuan Union reached the trading limit, and Shenzhou Cell, Guangsheng Tang, Shanghai Yizhong, and Rongchang Bio also saw significant gains